Pershing Square, Valeant to Pay $290 Million to Settle Allergan Suit

Posted on


  1. Pershing Square, Valeant to Pay $290 Million to Settle Allergan Suit  Wall Street Journal
  2. Pershing Square and Valeant reach agreement on settlement split  Reuters
  3. Pershing Square Holdings, Ltd. Announces Transactions in Own Shares  Business Wire (press release)
  4. Full coverage



Pershing Square Capital Management and Valeant Pharmaceuticals are paying $ million to settle a lawsuit that alleged their trading in Allergan was illegal, allowing William Ackman to put behind him the last vestiges of an investment that created turmoil at his hedge fund.. Activist investor Bill Ackman's Pershing Square Holdings Ltd. and Valeant Pharmaceuticals International Inc. agreed to pay $ million to settle investor claims that they engaged in insider trading in the unsuccessful takeover bid for Botox maker Allergan Inc.. Activist investor Bill Ackman s Pershing Square Holdings Ltd. and Valeant Pharmaceuticals International Inc. agreed to pay US$ million to settle investor claims that they engaged in insider trading in the unsuccessful takeover bid for botox maker Allergan Inc. The deal, which requires the approval . , comes after Pershing Square and Valeant last week decided to pay $ million to settle the lawsuit that accused them of insider trading before bidding for Allergan Plc AGN.N in . The lawsuit was filed on behalf of investors who sold Allergan shares in the two months before Pershing Square .







Leave a Reply

Your email address will not be published. Required fields are marked *